Nippon Shinyaku Co.,Ltd.

4516 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥3,386.00
+0.80%
Delayed · cached 15 min

Fair value analysis

4516
Nippon Shinyaku Co.,Ltd.
PharmaceuticalsPharmaceutical
¥3,386.00
Close used for this calculation
¥6,141.85Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
81/100
Profitability15/25
Returns18/25
Balance Sheet23/25
Efficiency25/25
Growth14/25
Exceptional
Quality radar
81Prof.15/25Ret.18/25Eff.25/25B.Sht23/25Growth14/25

Consensus fair value

¥6,141.85
Below FV
▲ +81.4% against the close used
Model range ¥1,953.63 – ¥8,820.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥1,953.63Fair value¥6,141.85Bull¥8,820.00
FairClose
52-week traded range
52W low ¥3,213.0052W high ¥6,045.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Nippon Shinyaku Co.,Ltd. closed at ¥3,386.00, 44.9% below the consensus fair value of ¥6,141.85 drawn from 9 valuation models.

Financial DNA score 81/100 — Exceptional. P/E of 7.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
¥5,489.32
+62.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=4.4%, r=10%, tg=3%, n=10yr
Graham Number
¥6,214.33
+83.5%
√(22.5 × EPS × BVPS)
EPS=441, BVPS=3891.95
P/E Fair Value
¥8,820.00
+160.5%
EPS × 20x (sector P/E)
EPS=441, Sector P/E=20x
Peter Lynch (PEG)
¥1,953.63
-42.3%
EPS × Growth% (PEG = 1 is fair)
EPS=441, g=4.4%
EV/EBITDA
¥7,634.99
+125.5%
(EBITDA × 12.2x − Net Debt) ÷ Shares
EBITDA=42.13B
Dividend Discount (DDM)
¥2,323.48
-31.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=123.93, r=10%, g=4.4%
Book Value (P/B)
¥4,590.69
+35.6%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3891.95, ROE=11%, g=4.4%, r=10%
Reverse DCF
¥3,386.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -6.1% | Historical: 4.4%
Margin of Safety
¥5,130.91
+51.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=6841.22, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.